NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

動物疫苗的市場趨勢、市場佔有率、市場規模的預測 (2021-2028年):各產品、動物區分 (家禽、水生動物、反芻動物、寵物)、地區

Animal Vaccines Market Size, Share & Trends Analysis Report By Product, By Animal Type (Poultry, Aqua, Ruminants, Companion), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2021 - 2028

出版商 Grand View Research, Inc. 商品編碼 1007492
出版日期 內容資訊 英文 150 Pages
商品交期: 2-10個工作天內
價格
動物疫苗的市場趨勢、市場佔有率、市場規模的預測 (2021-2028年):各產品、動物區分 (家禽、水生動物、反芻動物、寵物)、地區 Animal Vaccines Market Size, Share & Trends Analysis Report By Product, By Animal Type (Poultry, Aqua, Ruminants, Companion), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2021 - 2028
出版日期: 2021年05月14日內容資訊: 英文 150 Pages
簡介

全球動物疫苗的市場規模在預測期間內預計以7.4%的年複合成長率發展,成長到2028年161億美元的規模。

糧食安全保障受到高度的關注,畜產業的成長,牛奶,雞肉,蛋,肉等動物性食品的需求擴大,寵物飼養增加和對寵物的健康意識高漲,企業的R&D投資增加等要素促進該市場的成長。

本報告提供全球動物疫苗的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19)以及其他的市場影響因素分析,法律制度,市場規模的變化、預測,產品、動物區分、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 調查手法、調查範圍

第2章 摘要整理

第3章 市場可變因素、趨勢、展望

  • 市場預測
  • 普及、成長預測製圖
  • 法律規範
  • 市場動態
  • 波特分析
  • PESTEL分析
  • 主要交易、策略性聯盟分析

第4章 競爭分析

  • 進入經營者的分類
  • 公開企業
  • 非公開企業

第5章 COVID-19:影響分析

第6章 市場預測、趨勢分析:各產品

  • 市場佔有率成果、預測
  • 減毒活病毒疫苗
  • 不活化疫苗
  • 次單元疫苗
  • DNA疫苗
  • 重組疫苗

第7章 市場預測、趨勢分析:各動物種類

  • 市場佔有率成果、預測
  • 家禽
  • 水生動物
  • 反芻動物
  • 寵物

第8章 市場預測、趨勢分析:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第9章 企業簡介

  • Merck & Co., Inc.
  • Zoetis
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Biogenesis Bago
  • Indian Immunologicals Ltd.
  • Elanco
  • Ceva
  • Phibro Animal Health Corporation
  • Neogen Corporation
  • Intas Pharmaceuticals Ltd.
  • Ourofino Saude Animal
目錄
Product Code: GVR-2-68038-053-8

Animal Vaccines Market Growth & Trends

The global animal vaccines market size is expected to reach USD 16.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2021 to 2028. Rising concern about food security and increasing animal husbandry are boosting the demand for vaccines for the livestock population. Moreover, the growing demand for animal products, such as milk, chicken, eggs, and meat, is encouraging farmers to adopt vaccinations for their livestock to gain higher profitability.

The increasing outbreaks of cattle disease and the ever-expanding livestock population are the prime factors for the wide acceptance of the ruminants especially cattle vaccines globally. Moreover, rising pet ownership and increasing awareness regarding the health of companion animals are further propelling the growth. Moreover, the increasing number of R&D investments initiated by the companies is one of the key potential growth factors.

In June 2020, Boehringer Ingelheim received a new veterinary drug registration certificate from the Ministry of Agriculture & Rural Affairs of China for its classical swine fever vaccine. In July 2020, Biogenesis Bago partnered with the U.S. Department of Agriculture (USDA) as one of USDA's suppliers for antigens and vaccines for foot-and-mouth disease in livestock.

Animal Vaccines Market Report Highlights

Attenuated vaccines emerged as the largest segment in 2020 as a result of the benefits such as improved effectiveness and enhanced long-term prevention

The ruminants segment accounted for the largest revenue share in 2020 owing to the rise in the demand for safe livestock products

The poultry segment dominated the market in 2020 owing to the increase in demand for meat, worldwide

North America dominated the market and accounted for the largest revenue share in 2020. Constantly rising awareness regarding livestock health and increasing commercialization of livestock products are factors expected to drive the market in the region during the forecast period

In Asia Pacific, the market is projected to witness swift growth during the forecast period owing to the speedy adoption of animal vaccines for quality food products and better animal health

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Product
    • 1.1.2 Animal type
    • 1.1.3 Regional Scope
    • 1.1.4 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary Research:
    • 1.3.5 Details of Primary Research
      • 1.3.5.1 Data for primary interviews in North America
      • 1.3.5.2 Data for primary interviews in Europe
      • 1.3.5.3 Data for primary interviews in Asia Pacific
      • 1.3.5.4 Data for primary interviews in Latin America
      • 1.3.5.5 Data for primary interviews in Middle East and Africa
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 Report Objectives

Chapter 2 Executive Summary

  • 2.1 Market Outlook
    • 2.1.1 Animal Vaccines Market Outlook, 2016 - 2028 (USD Million)
  • 2.2 Segment Outlook
  • 2.3 Animal Vaccines Market Summary, 2020

Chapter 3 Animal Vaccines Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market analysis
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Regulatory Framework
  • 3.4 Animal Vaccines Market Dynamics
    • 3.4.1 Market driver analysis
      • 3.4.1.1 Rising livestock population and pet ownership
      • 3.4.1.2 Increasing disease outbreaks
      • 3.4.1.3 Rising R&D and manufacturing procedural advancements
      • 3.4.1.4 Growing demand for animal-derived food products
      • 3.4.1.5 regulatory mandates
    • 3.4.2 Market restraint analysis
      • 3.4.2.1 Government intervention
      • 3.4.2.2 Short product exclusivity period
      • 3.4.2.3 high storage cost of vaccines
  • 3.5 Animal Vaccines Market Analysis Tools: Porters
    • 3.5.1 Supplier Power: Low
    • 3.5.2 Buyer Power: moderate
    • 3.5.3 THREAT OF SUBSTITUTES: Low
    • 3.5.4 THREAT OF NEW ENTRANTS: Moderate
    • 3.5.5 Competitive Rivalry: High
  • 3.6 PESTEL Analysis
    • 3.6.1 Political landscape
    • 3.6.2 Economic landscape
    • 3.6.3 Social landscape
    • 3.6.4 Technology landscape
    • 3.6.5 Legal landscape
  • 3.7 Major Deals & Strategic Alliances Analysis
    • 3.7.1 Mergers & Acquisitions
    • 3.7.2 Product Launch
    • 3.7.3 Expansion

Chapter 4 Animal Vaccines Market: Competitive Analysis

  • 4.1 Market Participation Categorization
  • 4.2 Public Companies
    • 4.2.1 Company market share/position analysis
    • 4.2.2 Competitive Dashboard Analysis
  • 4.3 Private Companies
    • 4.3.1 List of key emerging companies

Chapter 5 Animal Vaccines Market: COVID Impact Analysis

  • 5.1 Impact of Disease Outbreak on The Market

Chapter 6 Animal Vaccines Market: Product Estimates & Trend Analysis

  • 6.1 Product Market Share Analysis, 2020 & 2028
  • 6.2 Product Dashboard
  • 6.3 Global Animal Vaccines Market, By Product, 2016 to 2028
    • 6.3.1 Attenuated live vaccines
      • 6.3.1.1 Attenuated live vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 6.3.2 Inactivated vaccines
      • 6.3.2.1 Inactivated vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 6.3.3 Subunit vaccines
      • 6.3.3.1 Subunit vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 6.3.4 DNA vaccines
      • 6.3.4.1 DNA vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 6.3.5 Recombinant vaccines
      • 6.3.5.1 Recombinant vaccines market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 7 Animal Vaccines Market: Animal type Estimates & Trend Analysis

  • 7.1 Animal Type Market Share Analysis, 2020 & 2028
  • 7.2 Animal Type Dashboard
    • 7.2.1 Poultry
      • 7.2.1.1 Poultry Market by disease type
      • 7.2.1.2 Infectious bronchitis
      • 7.2.1.2.1 INFECTIOUS BRONCHITIS market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.1.3 Avian influenza
      • 7.2.1.3.1 Avian influenza market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.1.4 Marek's disease
      • 7.2.1.4.1 Marek's disease market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.1.5 Newcastle disease
      • 7.2.1.5.1 NEWCASTLE DISEASE market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.1.6 Salmonella
      • 7.2.1.6.1 Salmonella market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.1.7 Others
      • 7.2.1.7.1 Others market estimates and forecasts, 2016 - 2028 (USD Million)
    • 7.2.2 Aqua
      • 7.2.2.1 Aqua Market by disease type
      • 7.2.2.2 Bacterial
      • 7.2.2.2.1 Bacterial market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.2.3 Viral
      • 7.2.2.3.1 Viral market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.2.4 Others
      • 7.2.2.4.1 Others market estimates and forecasts, 2016 - 2028 (USD Million)
    • 7.2.3 Ruminants
      • 7.2.3.1 Ruminants Market by disease type
      • 7.2.3.2 Foot & mouth disease (FMD)
      • 7.2.3.2.1 FOOT & MOUTH DISEASE (FMD) market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.3.3 Lumpy skin
      • 7.2.3.3.1 Lumpy skin market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.3.4 Rotavirus
      • 7.2.3.4.1 Rotavirus market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.3.5 Coronavirus
      • 7.2.3.5.1 CORONAVIRUS drugs market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.3.6 E. COLI
      • 7.2.3.6.1 E. COLI market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.3.7 Others
      • 7.2.3.7.1 Others market estimates and forecasts, 2016 - 2028 (USD Million)
    • 7.2.4 Companion
      • 7.2.4.1 Canine Market by disease type
      • 7.2.4.2 Distemper
      • 7.2.4.2.1 DISTEMPER market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.4.3 Kennel cough
      • 7.2.4.3.1 Kennel cough market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.4.4 Parvovirus
      • 7.2.4.4.1 Parvovirus market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.4.5 Canine herpes
      • 7.2.4.5.1 CANINE HERPES drugs market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.4.6 Lyme disease
      • 7.2.4.6.1 Lyme disease market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.4.7 Rabies
      • 7.2.4.7.1 Rabies market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.4.8 Feline Market by disease type
      • 7.2.4.9 Rhinotracheitis
      • 7.2.4.9.1 Rhinotracheitis market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.4.10 Calicivirus
      • 7.2.4.10.1 Calicivirus market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.4.11 Corona virus
      • 7.2.4.11.1 Corona virus market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.4.12 Panleukopenia
      • 7.2.4.12.1 Panleukopenia market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.4.13 Rabies
      • 7.2.4.13.1 Rabies market estimates and forecasts, 2016 - 2028 (USD Million)
    • 7.2.5 Swine
      • 7.2.5.1 Swine market estimates and forecasts, by disease type
      • 7.2.5.2 Swine influenza
      • 7.2.5.2.1 swine influenza market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.5.3 Classical Swine Fever (CSF)
      • 7.2.5.3.1 CSF market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.5.4 Porcine Parvovirus (PPV)
      • 7.2.5.4.1 PPV market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.5.5 Porcine Circovirus Type 2 (PCV2)
      • 7.2.5.5.1 PCV2 market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.5.6 M. Hyo
      • 7.2.5.6.1 M.Hyo market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.5.7 Actinobacillus Pleuropneumoniae
      • 7.2.5.7.1 Actinobacillus Pleuropneumoniae market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.5.8 PRRS
      • 7.2.5.8.1 PRRS market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.5.9 Foot & mouth disease
      • 7.2.5.9.1 FMD disease market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.5.10 Pseudorabies
      • 7.2.5.10.1 pseudorabies market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.5.11 PEDV (coronavirus)
      • 7.2.5.11.1 PEDV market estimates and forecasts, 2016 - 2028 (USD Million)
      • 7.2.5.12 Others
      • 7.2.5.12.1 Others market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 8 Animal Vaccines Market: Regional Estimates & Trend Analysis, by, Product, Animal Type

  • 8.1 Regional Market Snapshot
  • 8.2 North America
    • 8.2.1 North America Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Animal Vaccines market estimates and forecasts, 2016 - 2028(USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.3.2 U.K.
      • 8.3.2.1 U.K. Animal Vaccines market estimates and forecasts, 2016 - 2028(USD Million)
    • 8.3.3 Germany
      • 8.3.3.1 Germany Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.3.4 France
      • 8.3.4.1 France Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.3.5 Italy
      • 8.3.5.1 Italy Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.3.6 Spain
      • 8.3.6.1 Spain Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.4.5 Australia
      • 8.4.5.1 Australia Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Argentina Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
  • 8.6 MEA
    • 8.6.1 MEA Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Saudi Arabia Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 9 Company Profiles

  • 9.1 Merck & Co., Inc.
    • 9.1.1 Company overview
    • 9.1.2 Financial performance
    • 9.1.3 Product benchmarking
    • 9.1.4 Strategic initiatives
  • 9.2 Zoetis
    • 9.2.1 Company overview
    • 9.2.2 Financial performance
    • 9.2.3 Product benchmarking
    • 9.2.4 Strategic initiatives
  • 9.3 Boehringer Ingelheim International GmbH
    • 9.3.1 Company overview
    • 9.3.2 Financial performance
    • 9.3.3 Product benchmarking
    • 9.3.4 Strategic initiatives
  • 9.4 Virbac
    • 9.4.1 Company overview
    • 9.4.2 Financial performance
    • 9.4.3 Product benchmarking
    • 9.4.4 Strategic initiatives
  • 9.5 Biogenesis Bago
    • 9.5.1 Company overview
    • 9.5.2 FINANCIAL PERFORMANCE
    • 9.5.3 Product benchmarking
    • 9.5.4 Strategic initiatives
  • 9.6 Indian Immunologicals Ltd.
    • 9.6.1 Company overview
    • 9.6.2 Product benchmarking
    • 9.6.3 Strategic initiatives
  • 9.7 Elanco
    • 9.7.1 Company overview
    • 9.7.2 Financial performance
    • 9.7.3 Product benchmarking
    • 9.7.4 Strategic initiatives
  • 9.8 Ceva
    • 9.8.1 Company overview
    • 9.8.2 FINANCIAL PERFORMANCE
    • 9.8.3 R&D Investment
    • 9.8.4 Product benchmarking
    • 9.8.5 Strategic initiatives
  • 9.9 Phibro Animal Health Corporation
    • 9.9.1 Company overview
    • 9.9.2 Financial performance
    • 9.9.3 Product benchmarking
    • 9.9.4 Strategic initiatives
  • 9.10 Neogen Corporation
    • 9.10.1 Company overview
    • 9.10.2 Financial performance
    • 9.10.3 Product benchmarking
    • 9.10.4 Strategic initiatives
  • 9.11 Intas Pharmaceuticals Ltd.
    • 9.11.1 Company overview
    • 9.11.2 Financial performance
    • 9.11.3 Product benchmarking
    • 9.11.4 Strategic initiatives
  • 9.12 Ourofino Saude Animal
    • 9.12.1 Company overview
    • 9.12.2 Financial performance
    • 9.12.3 Product benchmarking
    • 9.12.4 Strategic initiatives

List of Tables

  • TABLE 1 North America veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 2 North America veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 3 U.S. veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 4 U.S. veterinary vaccines market, by animal type, 2016 - 2028 (USD million)
  • TABLE 5 Canada veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 6 Canada veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 7 Europe veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 8 Europe veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 9 U.K. veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 10 U.K. veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 11 Germany veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 12 Germany veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 13 France veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 14 France veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 15 Italy veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 16 Italy veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 17 Spain veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 18 Spain veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 19 Asia Pacific veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 20 Asia Pacific veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 21 Japan veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 22 Japan veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 23 China veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 24 China veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 25 India veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 26 India veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 27 Australia veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 28 Australia veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 29 Latin America veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 30 Latin America veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 31 Brazil veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 32 Brazil veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 33 Mexico veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 34 Mexico veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 35 Argentina veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 36 Argentina veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 37 MEA veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 38 MEA veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 39 South Africa veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 40 South Africa veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
  • TABLE 41 Saudi Arabia veterinary vaccines market, by product, 2016 - 2028 (USD Million)
  • TABLE 42 Saudi Arabia veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Primary interviews in North America
  • Fig. 6 Primary interviews in Europe
  • Fig. 7 Primary interviews in Asia Pacific
  • Fig. 8 Primary interviews in Latin America
  • Fig. 9 Primary interviews in Middle East and Africa
  • Fig. 10 Market research approaches
  • Fig. 11 Value-chain-based sizing & forecasting
  • Fig. 12 QFD modeling for market share assessment
  • Fig. 13 Market formulation & validation
  • Fig. 14 Commodity flow analysis
  • Fig. 15 Animal Vaccines market revenue, 2016 - 2028 (USD Million)
  • Fig. 16 Animal vaccines market snapshot (USD Million)
  • Fig. 17 Penetration & growth prospect mapping
  • Fig. 18 Animal vaccines market dynamics
  • Fig. 19 Animal vaccines market driver impact
  • Fig. 20 Estimated pet population in the U.S., 2015 - 2019 (million)
  • Fig. 21 Animal Vaccines market restraint impact
  • Fig. 22 Strategy mapping
  • Fig. 23 Market participant categorization
  • Fig. 24 Company market position analysis
  • Fig. 25 Competitive dashboard analysis
  • Fig. 26 Animal vaccines market: Product movement analysis
  • Fig. 27 Animal vaccines market product dashboard
  • Fig. 28 Animal vaccines market by product
  • Fig. 29 Global attenuated live vaccines market, 2016 - 2028 (USD Million)
  • Fig. 30 Global inactivated vaccines market, 2016 - 2028 (USD Million)
  • Fig. 31 Global subunit vaccines market, 2016 - 2028 (USD Million)
  • Fig. 32 Global DNA vaccines market, 2016 - 2028 (USD Million)
  • Fig. 33 Global recombinant vaccines market, 2016 - 2028 (USD Million)
  • Fig. 34 Animal vaccines market: Animal type movement analysis
  • Fig. 35 Animal vaccines animal type dashboard
  • Fig. 36 Global infectious bronchitis market, 2016 - 2028 (USD Million)
  • Fig. 37 Global avian influenza market, 2016 - 2028 (USD Million)
  • Fig. 38 Global Marek's disease market, 2016 - 2028 (USD Million)
  • Fig. 39 Global newcastle disease market, 2016 - 2028 (USD Million)
  • Fig. 40 Global salmonella market, 2016 - 2028 (USD Million)
  • Fig. 41 Global bacterial market, 2016 - 2028 (USD Million)
  • Fig. 42 Global viral market, 2016 - 2028 (USD Million)
  • Fig. 43 Global others market, 2016 - 2028 (USD Million)
  • Fig. 44 Global foot & mouth disease (FMD) market, 2016 - 2028 (USD Million)
  • Fig. 45 Global lumpy skin market, 2016 - 2028 (USD Million)
  • Fig. 46 Global Rotavirus market, 2016 - 2028 (USD Million)
  • Fig. 47 Global corona virus market, 2016 - 2028 (USD Million)
  • Fig. 48 Global e.coli market, 2016 - 2028 (USD Million)
  • Fig. 49 Global others market, 2016 - 2028 (USD Million)
  • Fig. 50 Global distemper market, 2016 - 2028 (USD Million)
  • Fig. 51 Global kennel cough market, 2016 - 2028 (USD Million)
  • Fig. 52 Global Parvovirusmarket, 2016 - 2028 (USD Million)
  • Fig. 53 Global canine herpes market, 2016 - 2028 (USD Million)
  • Fig. 54 Global lyme disease market, 2016 - 2028 (USD Million)
  • Fig. 55 Global rabies market, 2016 - 2028 (USD Million)
  • Fig. 56 Global rhinotracheitis market, 2016 - 2028 (USD Million)
  • Fig. 57 Global calcivirus market, 2016 - 2028 (USD Million)
  • Fig. 58 Global corona virus market, 2016 - 2028 (USD Million)
  • Fig. 59 Global panleukopenia market, 2016 - 2028 (USD Million)
  • Fig. 60 Global rabies market, 2016 - 2028 (USD Million)
  • Fig. 61 Global swine influenza market, 2016 - 2028 (USD Million)
  • Fig. 62 Global classical swine fever market, 2016 - 2028 (USD Million)
  • Fig. 63 Global Porcine Parvovirus (PPV) drugs market, 2016 - 2028 (USD Million)
  • Fig. 64 Global Porcine Circovirus type 2 (PCV2) market, 2016 - 2028 (USD Million)
  • Fig. 65 Global M.Hyo market, 2016 - 2028 (USD Million)
  • Fig. 66 Global Actinobacillus Pleuropneumoniae market, 2016 - 2028 (USD Million)
  • Fig. 67 Global PRRS market, 2016 - 2028 (USD Million)
  • Fig. 68 Global Foot & mouth disease market, 2016 - 2028 (USD Million)
  • Fig. 69 Global pseudorabies market, 2016 - 2028 (USD Million)
  • Fig. 70 Global PEDV (coronavirus) market, 2016 - 2028 (USD Million)
  • Fig. 71 Global others market, 2016 - 2028 (USD Million)
  • Fig. 72 Regional market place: Key takeaways
  • Fig. 73 Regional outlook, 2020 & 2028
  • Fig. 74 North America Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 75 U.S. Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 76 Canada Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 77 Europe Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 78 U.K. Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 79 Germany Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 80 France Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 81 Italy Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 82 Spain Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 83 Asia Pacific Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 84 Japan Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 85 China Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 86 India Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 87 Australia Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 88 Latin America Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 89 Brazil Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 90 Mexico Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 91 Argentina Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 92 MEA Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 93 South Africa Animal Vaccines market, 2016 - 2028 (USD Million)
  • Fig. 94 Saudi Arabia Animal Vaccines market, 2016 - 2028 (USD Million)